RECRUITING

The Will Erwin Headache Research Center - Cluster Headache Study

Talk to us

Conditions

Cluster HeadacheCluster Headaches and Other Trigeminal Autonomic CephalgiasParoxysmal HemicraniaSUNCTHemicrania ContinuaTrigeminal Neuralgia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.

Official Title

The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia

Quick Facts

Study Start:2016-05
Study Completion:2035-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02910323

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of a trigeminal autonomic cephalalgia according to the International Headache Classification including episodic cluster headache, chronic cluster headache, episodic paroxysmal hemicrania, chronic paroxysmal hemicrania, episodic short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), chronic SUNCT, episodic short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), chronic SUNA, and hemicrania continua. OR Diagnosis of a trigeminal neuralgia according to the International Headache Classification, including classical trigeminal neuralgia and symptomatic trigeminal neuralgia.
  2. * Able to provide HIPAA authorization to share prior medical records/imaging.
  1. * Life expectancy less than 1 year, co-existing disease or other characteristic that precludes appropriate diagnosis of a trigeminal autonomic cephalalgia or trigeminal neuralgia.
  2. * Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements
  3. * Inability or unwillingness of subject or legal guardian/representative to give informed consent.
  4. * Inclusion criteria is willingness to consent and be of age 18 and older

Contacts and Locations

Study Contact

Rebecca Martinez, RN
CONTACT
713-486-7771
nctt.wec@uth.tmc.edu
Mark J Burish, MD, PhD
CONTACT
713-486-7771

Principal Investigator

Mark Burish, MD, PhD
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

The University of Texas Health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Mark Burish, MD, PhD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-05
Study Completion Date2035-12

Study Record Updates

Study Start Date2016-05
Study Completion Date2035-12

Terms related to this study

Additional Relevant MeSH Terms

  • Cluster Headache
  • Cluster Headaches and Other Trigeminal Autonomic Cephalgias
  • Paroxysmal Hemicrania
  • SUNCT
  • Hemicrania Continua
  • Trigeminal Neuralgia